Immunology, Inflammation, Asthma, Lung and Proinflammatory cytokine are his primary areas of study. His Immunology research is multidisciplinary, incorporating perspectives in Receptor, Lung injury and Airway. His Inflammation research incorporates themes from Eosinophil, Resolvin, Maresin, Mediator and Innate lymphoid cell.
The concepts of his Asthma study are interwoven with issues in Disease, Intensive care and Eicosanoid. His studies in Lung integrate themes in fields like Disease susceptibility and Pneumonia. While the research belongs to areas of Proinflammatory cytokine, he spends his time largely on the problem of Methacholine, intersecting his research to questions surrounding Allergen, Macrophage and Aeroallergen.
His main research concerns Immunology, Inflammation, Asthma, Internal medicine and Lung. The study incorporates disciplines such as Receptor and Bronchoalveolar lavage in addition to Immunology. The Inflammation study combines topics in areas such as Resolvin, Eosinophil, Tissue homeostasis and Maresin.
His work in the fields of Asthma, such as Airway inflammation, intersects with other areas such as Sputum. His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Genotype. In his study, which falls under the umbrella issue of Lipid signaling, Cell is strongly linked to Cell biology.
Bruce D. Levy mostly deals with Immunology, Asthma, Internal medicine, Severe asthma and Inflammation. His biological study spans a wide range of topics, including Expression quantitative trait loci and Gene expression, Gene. He has included themes like Odds ratio, Airway, Pediatrics and Cohort in his Asthma study.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Genotype and Cardiology. In his research on the topic of Severe asthma, Eosinophil is strongly related with Lung function. Bruce D. Levy interconnects Lidocaine, Guinea pig, Systems biology, Clinical phenotype and Tissue damage in the investigation of issues within Inflammation.
The scientist’s investigation covers issues in Asthma, Immunology, Internal medicine, Sputum and Inflammation. His Asthma research incorporates themes from Interleukin 6 and Cohort. His work in Interleukin 6 addresses subjects such as Asthma severity, which are connected to disciplines such as Lung.
His research on Immunology often connects related areas such as Peripheral blood mononuclear cell. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Allele and Genotype. His work in the fields of Inflammation resolution overlaps with other areas such as Clinical decision making.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
Joshua A. Boyce;Amal Assa'ad;A. Wesley Burks;Stacie M. Jones.
The Journal of Allergy and Clinical Immunology (2011)
Lipid mediator class switching during acute inflammation: signals in resolution
Bruce D. Levy;Clary B. Clish;Birgitta Schmidt;Karsten Gronert.
Nature Immunology (2001)
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
Wendy C. Moore;Eugene R. Bleecker;Douglas Curran-Everett;Serpil C. Erzurum.
The Journal of Allergy and Clinical Immunology (2007)
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators.
Charles N. Serhan;Bruce D. Levy.
Journal of Clinical Investigation (2018)
Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation.
Oliver Haworth;Manuela Cernadas;Rong Yang;Charles N Serhan.
Nature Immunology (2008)
RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis
H. Hasturk;A. Kantarci;T. Ohira;M. Arita.
The FASEB Journal (2006)
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
Maria C. Basil;Bruce D. Levy.
Nature Reviews Immunology (2016)
Lipoxin A4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma
Cindy Barnig;Manuela Cernadas;Stefanie Dutile;Xiaoli Liu.
Science Translational Medicine (2013)
Lipid Mediators in the Resolution of Inflammation
Charles N. Serhan;Nan Chiang;Jesmond Dalli;Bruce D. Levy.
Cold Spring Harbor Perspectives in Biology (2015)
The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation
Antonia Wallrapp;Samantha J. Riesenfeld;Patrick R. Burkett;Raja-Elie E. Abdulnour.
Nature (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Brigham and Women's Hospital
University of Pittsburgh
Brigham and Women's Hospital
University of Arizona
University of California, San Francisco
University of Wisconsin–Madison
Cleveland Clinic Lerner College of Medicine
Washington University in St. Louis
Harvard Medical School
Wake Forest University
Heidelberg Institute for Theoretical Studies
Bocconi University
Federico Santa María Technical University
Xi'an Jiaotong University
University of California, Berkeley
King's College London
Sichuan University
McGill University
University of California, Santa Cruz
Helmholtz Association of German Research Centres
University of Graz
Virginia Mason Medical Center
The University of Texas Health Science Center at San Antonio
University of Ulsan
University of California, Los Angeles
University of Minnesota